Yuichi Tabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuichi Tabe has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Kuwano
General Surgical Science, Graduate school of medicine, Gunma University, Maebashi, Gunma, Japan
13 shared publications- Takayuki Asao
Gunma University Center for Mathematics and Data Science, Gunma, Japan
10 shared publications Hiroki Morita
6 shared publications- Reina Yajima
Department of General Surgical Science, Graduate School of Medicine, Gunma University, Gunma, Japan
6 shared publications - Satoru Yamaguchi
First Department of Surgery, Dokkyo Medical University, Tochigi, Japan
6 shared publications Soichi Tsutsumi
6 shared publications
Latest Publications
- 1 May 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 81 (5) , AB310
Su1509 Safety and Efficacy of Propofol Sedation Without Local Pharyngeal Anesthesia for Gastric Endoscopic Submucosal Dissection
- 1 May 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 81 (5) , AB310
Su1509 Safety and Efficacy of Propofol Sedation Without Local Pharyngeal Anesthesia for Gastric Endoscopic Submucosal Dissection
- 1 September 2013
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 60 (126) , 1343-7
Elevated C-reactive protein is associated with the tumor depth of invasion but not with disease recurrence in stage II and III colorectal cancer.
We previously demonstrated that elevated serum C-reactive protein (CRP) level is associated with depth of tumor invasion in operable colorectal cancer. There is also increasing evidence to show that raised CRP concentration is associated with poor survival in patients with colorectal cancer. The purpose of this study was to investigate the correlation between preoperative CRP concentrations and short-term disease recurrence in cases with stage II and III colorectal cancer. Of the 224 cases with resected colorectal cancer, 55 patients with TNM stage II and 50 with stage III were analyzed in this study. The clinical features were reviewed according to the CRP level, and statistical analysis was performed. In cases with stage II and III, 11 and 6 of which had elevated serum CRP (>=10mg/L), respectively. Recurrence-free interval was defined as the interval from surgery to the time disease recurrence was diagnosed. Among the cases with stage II and III colorectal cancer, 4 and 10 had recurrent disease. Among various clinicopathological characteristics, depth of tumor invasion was independently associated with preoperative elevation of CRP in stage II and III colorectal cancer in multivariate subgroup analysis. However, recurrence-free interval by Kaplan-Meier curves did not differ significantly among patients with preoperative CRP concentrations. Our results suggest that elevated serum CRP level is associated with depth of tumor, but not with recurrent disease in stage II and III colorectal cancer.
- 1 September 2013
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 60 (126) , 1343-7
Elevated C-reactive protein is associated with the tumor depth of invasion but not with disease recurrence in stage II and III colorectal cancer.
We previously demonstrated that elevated serum C-reactive protein (CRP) level is associated with depth of tumor invasion in operable colorectal cancer. There is also increasing evidence to show that raised CRP concentration is associated with poor survival in patients with colorectal cancer. The purpose of this study was to investigate the correlation between preoperative CRP concentrations and short-term disease recurrence in cases with stage II and III colorectal cancer. Of the 224 cases with resected colorectal cancer, 55 patients with TNM stage II and 50 with stage III were analyzed in this study. The clinical features were reviewed according to the CRP level, and statistical analysis was performed. In cases with stage II and III, 11 and 6 of which had elevated serum CRP (>=10mg/L), respectively. Recurrence-free interval was defined as the interval from surgery to the time disease recurrence was diagnosed. Among the cases with stage II and III colorectal cancer, 4 and 10 had recurrent disease. Among various clinicopathological characteristics, depth of tumor invasion was independently associated with preoperative elevation of CRP in stage II and III colorectal cancer in multivariate subgroup analysis. However, recurrence-free interval by Kaplan-Meier curves did not differ significantly among patients with preoperative CRP concentrations. Our results suggest that elevated serum CRP level is associated with depth of tumor, but not with recurrent disease in stage II and III colorectal cancer.
- 22 November 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (120) , 2477-9
The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer.
The advantages of combined pharmacological and physical methods for venous thromboembolism (VTE) prophylaxis after colorectal surgery have not been clearly determined. The aim of this study is to compare the efficacy and safety of fondaparinux combined with intermittent pneumatic compression (IPC) with IPC alone for VTE prophylaxis after resection for colorectal cancer. Between June 2008 and March 2010, 137 consecutive patients with colorectal cancer (CRC) who underwent colorectal resection in our surgical unit were enrolled in the study. Patients were divided into 2 groups. The IPC group was treated with IPC alone as controls. The fondaparinux group was treated with IPC and received subcutaneous injections of fondaparinux once daily. The aim of this study was to compare the efficacy and safety of fondaparinux combined with IPC with IPC alone for VTE prophylaxis. The demographic variables and risk factors, operating time, blood loss and length of the postoperative hospital stay were similar in the two groups. No clinically evident VTE, critical bleeding, and postoperative death occurred during the study period. No adverse reactions due to fondaparinux were observed. In patients undergoing resection of colorectal cancer, receiving fondaparinux and IPC thromboprophylaxis was highly effective, well tolerated and safe. The use of combined modalities for VTE prophylaxis is justified in patients at high risk of VTE.
- 22 November 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (120) , 2477-9
The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer.
The advantages of combined pharmacological and physical methods for venous thromboembolism (VTE) prophylaxis after colorectal surgery have not been clearly determined. The aim of this study is to compare the efficacy and safety of fondaparinux combined with intermittent pneumatic compression (IPC) with IPC alone for VTE prophylaxis after resection for colorectal cancer. Between June 2008 and March 2010, 137 consecutive patients with colorectal cancer (CRC) who underwent colorectal resection in our surgical unit were enrolled in the study. Patients were divided into 2 groups. The IPC group was treated with IPC alone as controls. The fondaparinux group was treated with IPC and received subcutaneous injections of fondaparinux once daily. The aim of this study was to compare the efficacy and safety of fondaparinux combined with IPC with IPC alone for VTE prophylaxis. The demographic variables and risk factors, operating time, blood loss and length of the postoperative hospital stay were similar in the two groups. No clinically evident VTE, critical bleeding, and postoperative death occurred during the study period. No adverse reactions due to fondaparinux were observed. In patients undergoing resection of colorectal cancer, receiving fondaparinux and IPC thromboprophylaxis was highly effective, well tolerated and safe. The use of combined modalities for VTE prophylaxis is justified in patients at high risk of VTE.
- 1 June 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (116) , 1079-80
Central venous port system-related complications in outpatient chemotherapy for colorectal cancer.
The current standard chemotherapy for metastatic colorectal cancer is the FOLFOX or the FOLFIRI regimen. Although these regimens include the continuous infusion of an anticancer agent, chemotherapy is possible by using implantable central venous port systems with a portable disposable pump in an outpatient setting. This study is an evaluation of the usefulness of implantable central venous port systems for colorectal cancer chemotherapy. An implantable central venous port system was placed in 93 consecutive patients with metastatic colorectal cancer. All patients received modified FOLFOX6 ± bevacizumab or FOLFIRI ± bevacizumab regimens via the port system. Follow-up continued for each patient until removal of the port system, death or unavailability of further information. The incidence and details of the complications were investigated retrospectively. Out of 1,246 treatments, a total of 16 incidents of port system-related complications were identified (1.28%). Incidents involved infections (n=12), catheter pinch off (n=2), fibrin sheath (n=1) and drug leakage (n=1). A port system removal was required in 14 cases. Implantable central venous port systems are safe and have a low long-term complication rate. We consider port systems, such as modified FOLFOX6 ± bevacizumab or FOLFIRI ± bevacizumab regimens, useful for colorectal cancer patients receiving chemotherapy.
- 1 June 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (116) , 1079-80
Central venous port system-related complications in outpatient chemotherapy for colorectal cancer.
The current standard chemotherapy for metastatic colorectal cancer is the FOLFOX or the FOLFIRI regimen. Although these regimens include the continuous infusion of an anticancer agent, chemotherapy is possible by using implantable central venous port systems with a portable disposable pump in an outpatient setting. This study is an evaluation of the usefulness of implantable central venous port systems for colorectal cancer chemotherapy. An implantable central venous port system was placed in 93 consecutive patients with metastatic colorectal cancer. All patients received modified FOLFOX6 ± bevacizumab or FOLFIRI ± bevacizumab regimens via the port system. Follow-up continued for each patient until removal of the port system, death or unavailability of further information. The incidence and details of the complications were investigated retrospectively. Out of 1,246 treatments, a total of 16 incidents of port system-related complications were identified (1.28%). Incidents involved infections (n=12), catheter pinch off (n=2), fibrin sheath (n=1) and drug leakage (n=1). A port system removal was required in 14 cases. Implantable central venous port systems are safe and have a low long-term complication rate. We consider port systems, such as modified FOLFOX6 ± bevacizumab or FOLFIRI ± bevacizumab regimens, useful for colorectal cancer patients receiving chemotherapy.
- 23 February 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (114) , 372-4
Extranodal metastasis predicts poor survival in advanced colorectal cancer.
The prognostic significance of extranodal metastasis (ENM) in colorectal cancer (CRC) is disregarded by the TNM classification system. The influence of ENM on survival among locally advanced CRC patients was examined. We reviewed retrospectively the clinical course of 263 patients who underwent surgical resection of locally advanced CRC at our Department between 2005 and 2009. We analyzed the prognostic factors with special reference to the clinicopathological factors of primary tumors. Thirty-eight cases of ENM were detected among patients with CRC. Compared with ENM negative cancers, ENM-positive cancers were associated with poorer tumor differentiation grade (p=0.026) and higher prevalence of TNM-stage (p<0.0001), T-status (p=0.024), N-status (p<0.0001) and postoperative recurrence (p<0.0001). In univariate analysis, TNM-stage (p<0.0035), T-status (p=0.002), N-status (p<0.0024) and positive ENM (p<0.0001) were significant predictors of poor survival. Multivariate analyses showed a positive ENM to be a highly significant independent predictor of mortality (HR=1.98, 95% CI=1.23- 3.23, p=0.0053). Survival analyses using Kaplan-Meier curves demonstrated that patients with ENM-positive cancers had significantly poorer survival than patients with ENM-negative cancers. Patients with ENM-negative cancers did not show significantly different survival from patients with node-negative cancers (p=0.272, data not shown). ENM appears to be a strong independent negative prognostic factor of poor survival in locally advanced CRC.
- 23 February 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (114) , 372-4
Extranodal metastasis predicts poor survival in advanced colorectal cancer.
The prognostic significance of extranodal metastasis (ENM) in colorectal cancer (CRC) is disregarded by the TNM classification system. The influence of ENM on survival among locally advanced CRC patients was examined. We reviewed retrospectively the clinical course of 263 patients who underwent surgical resection of locally advanced CRC at our Department between 2005 and 2009. We analyzed the prognostic factors with special reference to the clinicopathological factors of primary tumors. Thirty-eight cases of ENM were detected among patients with CRC. Compared with ENM negative cancers, ENM-positive cancers were associated with poorer tumor differentiation grade (p=0.026) and higher prevalence of TNM-stage (p<0.0001), T-status (p=0.024), N-status (p<0.0001) and postoperative recurrence (p<0.0001). In univariate analysis, TNM-stage (p<0.0035), T-status (p=0.002), N-status (p<0.0024) and positive ENM (p<0.0001) were significant predictors of poor survival. Multivariate analyses showed a positive ENM to be a highly significant independent predictor of mortality (HR=1.98, 95% CI=1.23- 3.23, p=0.0053). Survival analyses using Kaplan-Meier curves demonstrated that patients with ENM-positive cancers had significantly poorer survival than patients with ENM-negative cancers. Patients with ENM-negative cancers did not show significantly different survival from patients with node-negative cancers (p=0.272, data not shown). ENM appears to be a strong independent negative prognostic factor of poor survival in locally advanced CRC.
- 19 January 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (113) , 101-3
Feasibility of solo laparoscopic colorectal resection.
To demonstrate the feasibility of solo laparoscopic colorectal resection (SLCR) is performed by the laparoscopist only. This study is an evaluation of the feasibility of SLCR for patients with colorectal cancer. Fifty-one consecutive patients received SLCR from 2008 to 2009. The procedure was performed with four trocars and one laparoscopist. The short-term outcomes and complications were investigated retrospectively. The median age of the patients was 67 years (range 42-81). The median operating time for SLCR was 168 minutes (range 90-268). For one patient (1.96%) conversion to open surgery was required. Anastomotic leakage developed in 1 (1.96%) patient and ileus developed in 2 (3.9%). The median postoperative hospital stay was 8 (range 6-60) days without in-hospital deaths. In our experience, SLCR for patients with colorectal cancer is feasible and compares favorably with the standard technique. The diminished need for human operative assistance provides significant economic and organizational benefits.
- 19 January 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 59 (113) , 101-3
Feasibility of solo laparoscopic colorectal resection.
To demonstrate the feasibility of solo laparoscopic colorectal resection (SLCR) is performed by the laparoscopist only. This study is an evaluation of the feasibility of SLCR for patients with colorectal cancer. Fifty-one consecutive patients received SLCR from 2008 to 2009. The procedure was performed with four trocars and one laparoscopist. The short-term outcomes and complications were investigated retrospectively. The median age of the patients was 67 years (range 42-81). The median operating time for SLCR was 168 minutes (range 90-268). For one patient (1.96%) conversion to open surgery was required. Anastomotic leakage developed in 1 (1.96%) patient and ileus developed in 2 (3.9%). The median postoperative hospital stay was 8 (range 6-60) days without in-hospital deaths. In our experience, SLCR for patients with colorectal cancer is feasible and compares favorably with the standard technique. The diminished need for human operative assistance provides significant economic and organizational benefits.
- 12 January 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 58 (112) , 1930-2
Scheduled prospective tri-weekly modified FOLFOX6 maintenance chemotherapy in the treatment of metastatic colorectal cancer.
Oxaliplatin, which is effective for colorectal cancer (CRC) in combination with 5-fluorouracil (5-FU) and leucovorin (LV), is widely used for metastatic CRC. With the increasing use of oxaliplatin, however, serious adverse events have been experienced, including hematologic and neurologic toxicities. The aim of this study was to evaluate whether tri-weekly modified FOLFOX6 (mFOLFOX6) maintenance chemotherapy is associated with a low incidence of severe hematologic and neurologic toxicities in the treatment of patients with metastatic CRC. We developed a new treatment regimen with mFOLFOX6 biweekly for 8-10 consecutive cycles (induction phase) followed by a 3-week rest period, after which treatment was resumed with cycles of tri-weekly mFOLFOX6 at standard doses (maintenance phase). Validity and complications were investigated retrospectively. Twenty-nine patients were enrolled in this study. The median progression-free survival (PFS) and overall survival (OS) times were 9.4 months and 23 months, respectively. All patients had peripheral neuropathy during treatment, but grade 3 neurotoxicity was observed in only 2 patients (6.9%). mFOLFOX6 maintenance chemotherapy was associated with a very low incidence of grade 3 hematologic and neurologic toxicities. The toxicities associated with PFS and OS were comparable to those reported in the treatment of patients with metastatic CRC. A tri-weekly mFOLFOX maintenance strategy of alternative treatment with a less-toxic regimen may reduce toxicity and maintain efficacy.
- 12 January 2012
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 58 (112) , 1930-2
Scheduled prospective tri-weekly modified FOLFOX6 maintenance chemotherapy in the treatment of metastatic colorectal cancer.
Oxaliplatin, which is effective for colorectal cancer (CRC) in combination with 5-fluorouracil (5-FU) and leucovorin (LV), is widely used for metastatic CRC. With the increasing use of oxaliplatin, however, serious adverse events have been experienced, including hematologic and neurologic toxicities. The aim of this study was to evaluate whether tri-weekly modified FOLFOX6 (mFOLFOX6) maintenance chemotherapy is associated with a low incidence of severe hematologic and neurologic toxicities in the treatment of patients with metastatic CRC. We developed a new treatment regimen with mFOLFOX6 biweekly for 8-10 consecutive cycles (induction phase) followed by a 3-week rest period, after which treatment was resumed with cycles of tri-weekly mFOLFOX6 at standard doses (maintenance phase). Validity and complications were investigated retrospectively. Twenty-nine patients were enrolled in this study. The median progression-free survival (PFS) and overall survival (OS) times were 9.4 months and 23 months, respectively. All patients had peripheral neuropathy during treatment, but grade 3 neurotoxicity was observed in only 2 patients (6.9%). mFOLFOX6 maintenance chemotherapy was associated with a very low incidence of grade 3 hematologic and neurologic toxicities. The toxicities associated with PFS and OS were comparable to those reported in the treatment of patients with metastatic CRC. A tri-weekly mFOLFOX maintenance strategy of alternative treatment with a less-toxic regimen may reduce toxicity and maintain efficacy.
- 17 November 2011
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 58, 1470-3
Elevated C-reactive protein level is associated with the tumor depth of invasion in patients with operable colorectal carcinoma.
There is increasing evidence to show that the presence of raised concentrations of serum C-reactive protein (CRP) is associated with poor survival in patients with colorectal carcinoma. The CRP response with respect to tumor characteristics in colorectal carcinoma was examined to identify factors that might reflect a raised CRP level. One hundred and eighty-one patients who underwent elective colorectal resection were identified for inclusion in this study. Eighteen patients with high CRP levels were compared to a control group of 163 patients without high CRP levels, and the correlation between preoperative CRP level and clinicopathological features in operable colorectal carcinoma was investigated. The analysis of factors with seeming potential to be associated with CRP levels following colorectal surgery, disclosed that only the depth of tumor invasion, serum albumin and lymphovascular invasion were of statistical significance. Multivariate subgroup analysis of the association between these factors and CRP showed that depth of invasion and albumin were independently associated with CRP. Our results suggest that depth of tumor invasion is associated with an increase in CRP levels. CRP is considered an important indicator of advanced local invasion in operable colorectal surgery, if other inflammatory conditions are excluded.
- 17 November 2011
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 58, 1470-3
Elevated C-reactive protein level is associated with the tumor depth of invasion in patients with operable colorectal carcinoma.
There is increasing evidence to show that the presence of raised concentrations of serum C-reactive protein (CRP) is associated with poor survival in patients with colorectal carcinoma. The CRP response with respect to tumor characteristics in colorectal carcinoma was examined to identify factors that might reflect a raised CRP level. One hundred and eighty-one patients who underwent elective colorectal resection were identified for inclusion in this study. Eighteen patients with high CRP levels were compared to a control group of 163 patients without high CRP levels, and the correlation between preoperative CRP level and clinicopathological features in operable colorectal carcinoma was investigated. The analysis of factors with seeming potential to be associated with CRP levels following colorectal surgery, disclosed that only the depth of tumor invasion, serum albumin and lymphovascular invasion were of statistical significance. Multivariate subgroup analysis of the association between these factors and CRP showed that depth of invasion and albumin were independently associated with CRP. Our results suggest that depth of tumor invasion is associated with an increase in CRP levels. CRP is considered an important indicator of advanced local invasion in operable colorectal surgery, if other inflammatory conditions are excluded.
- 12 October 2011
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 58 (112) , 1958-62
Cell to Cell Interaction in Clusters Enhances Thermosensitivity in HT29 Human Colon Cancer Cells
Tumor cells at high density are considered to be resistant to hyperthermia. Our objective in this study was to investigate hyperthermia sensitivity of clusters, cancer cell aggregation, compared with that of monolayer cells. Colon carcinoma cells HT29 were cultured on poly 2-hydroxyethyl methacrylate-coated dishes for 7 days and the clusters were selected by a 40µm pore filter. To detect the cell reproductive potential, a colony formation assay was performed in HT29 cells from a monolayer and from clusters after exposure to cis-diamino-dichloroplatinum, fluorouracil and/or hyperthermia. Western blotting was used to analyze the induction of heat shock protein expression by hyperthermia. Histological findings of the clusters less than 400µm in diameter showed dividing cells and no secondary central necrosis. Cluster cells were more sensitive to hyperthermia than monolayer cells (p<0.0001). However, cluster formation induced cis-diamino-dichloroplatinum resistance (p<0.0001). The enhancement of hyperthermia sensitivity in clusters was not observed when the cells were heated after dispersion to single cells (p<0.0001). No difference of heat-induced HSP70/72 and HSP27 expression between cluster cells and monolayer cells was found. Cluster formation induced hyperthermia sensitivity, and cell-to-cell interaction in the clusters might enhance hyperthermia sensitivity.
- 12 October 2011
- Published by Update Medical Publishing in Hepatogastroenterology
- Vol. 58 (112) , 1958-62
Cell to Cell Interaction in Clusters Enhances Thermosensitivity in HT29 Human Colon Cancer Cells
Tumor cells at high density are considered to be resistant to hyperthermia. Our objective in this study was to investigate hyperthermia sensitivity of clusters, cancer cell aggregation, compared with that of monolayer cells. Colon carcinoma cells HT29 were cultured on poly 2-hydroxyethyl methacrylate-coated dishes for 7 days and the clusters were selected by a 40µm pore filter. To detect the cell reproductive potential, a colony formation assay was performed in HT29 cells from a monolayer and from clusters after exposure to cis-diamino-dichloroplatinum, fluorouracil and/or hyperthermia. Western blotting was used to analyze the induction of heat shock protein expression by hyperthermia. Histological findings of the clusters less than 400µm in diameter showed dividing cells and no secondary central necrosis. Cluster cells were more sensitive to hyperthermia than monolayer cells (p<0.0001). However, cluster formation induced cis-diamino-dichloroplatinum resistance (p<0.0001). The enhancement of hyperthermia sensitivity in clusters was not observed when the cells were heated after dispersion to single cells (p<0.0001). No difference of heat-induced HSP70/72 and HSP27 expression between cluster cells and monolayer cells was found. Cluster formation induced hyperthermia sensitivity, and cell-to-cell interaction in the clusters might enhance hyperthermia sensitivity.
- 13 August 2011
- Vol. 58, 752-5
Relationship between C-reactive protein levels and wound infections in elective colorectal surgery: C-reactive protein as a predictor for incisional SSI.
Serum C-reactive protein (CRP) is an acknowledged marker of infections. For early detection of postoperative infections, CRP levels may be a useful marker. In this study, the CRP response with respect to wound infections (incisional surgical site infection (SSI)) in elective colorectal surgery was examined to define the role of serum CRP as a predictor of incisional SSI. One hundred forty-eight patients who underwent elective colorectal resection were identified for inclusion in this study. The outcome of interest was incisional SSI. Twenty-eight patients with incisional SSI were compared to a subgroup of 118 patients with an uneventful postoperative course, and the correlation between postoperative serum CRP levels and incisional SSI in colorectal surgery was investigated. For uneventful cases, the CRP rose postoperatively to a maximum on the third day, and the concentrations then returned to near normal levels on postoperative day (POD) 7. In incisional SSI cases, persistent elevation or a second rise in CRP concentrations was seen. Although no statistically significant differences in CRP concentrations were seen on POD 1 or 3, the initial rise in CRP of cases with incisional SSI was relatively higher compared to uneventful cases. A deviation became obvious at POD 7. A cut-off level of 36 mg/L on POD 7 was recorded (sensitivity of 71.4% and a specificity of 83.1%) for incisional SSI. Our results suggest that elevated serum CRP levels are correlated with incisional SSI. Persistent CRP elevation is predictive of incisional SSI in colorectal surgery if pneumonia or anastomotic leakage are unlikely or excluded.
- 13 August 2011
- Vol. 58, 752-5
Relationship between C-reactive protein levels and wound infections in elective colorectal surgery: C-reactive protein as a predictor for incisional SSI.
Serum C-reactive protein (CRP) is an acknowledged marker of infections. For early detection of postoperative infections, CRP levels may be a useful marker. In this study, the CRP response with respect to wound infections (incisional surgical site infection (SSI)) in elective colorectal surgery was examined to define the role of serum CRP as a predictor of incisional SSI. One hundred forty-eight patients who underwent elective colorectal resection were identified for inclusion in this study. The outcome of interest was incisional SSI. Twenty-eight patients with incisional SSI were compared to a subgroup of 118 patients with an uneventful postoperative course, and the correlation between postoperative serum CRP levels and incisional SSI in colorectal surgery was investigated. For uneventful cases, the CRP rose postoperatively to a maximum on the third day, and the concentrations then returned to near normal levels on postoperative day (POD) 7. In incisional SSI cases, persistent elevation or a second rise in CRP concentrations was seen. Although no statistically significant differences in CRP concentrations were seen on POD 1 or 3, the initial rise in CRP of cases with incisional SSI was relatively higher compared to uneventful cases. A deviation became obvious at POD 7. A cut-off level of 36 mg/L on POD 7 was recorded (sensitivity of 71.4% and a specificity of 83.1%) for incisional SSI. Our results suggest that elevated serum CRP levels are correlated with incisional SSI. Persistent CRP elevation is predictive of incisional SSI in colorectal surgery if pneumonia or anastomotic leakage are unlikely or excluded.